| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/25/2008 | US7348402 Antimicrobial peptide, its analogs and antimicrobial composition comprising them |
| 03/25/2008 | US7348401 Peptides that inhibit complement activation |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348315 Methods of treating heart failure with modified ATP, ADP and AMP compounds |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348308 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348165 Methods for detecting cancer cells by using nucleic acid encoding for IGF-1 receptor interacting proteins |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348161 Macrolide efflux genetic assembly |
| 03/25/2008 | US7348154 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on wild-type IGFBP-3 and IGF agonist peptides; KIRA phosphorylation |
| 03/25/2008 | US7348152 Using concentration of d-glactosides as diagnostic in detection of cancer; antitumor agents; immunoassay |
| 03/25/2008 | US7348151 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 03/25/2008 | US7348149 Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1 |
| 03/25/2008 | US7348146 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348136 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 03/25/2008 | US7348134 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening |
| 03/25/2008 | US7348014 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 03/25/2008 | US7348011 Hepatitis C virus vaccine |
| 03/25/2008 | US7348010 Contains at least one peptide with a length of 9 to 25 amino acids and a sequence as occurs in extracellular doamin of HER-2/neu protein, and the peptide or functional variants conjugated to an immunogenic carrier |
| 03/25/2008 | US7348009 Recombinant allergen with reduced enzymatic activity |
| 03/25/2008 | US7348008 Ricin-like toxins for treatment of cancer |
| 03/25/2008 | US7348007 Mage C2 antigenic peptides and uses thereof |
| 03/25/2008 | US7348004 Immunoglobulin chimeric monomer-dimer hybrids |
| 03/25/2008 | US7347998 Method of delivering therapeutic agents to site of tissue injury |
| 03/25/2008 | US7347996 Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2217679C Peptides and therapeutic agent for autoimmune diseases containing the same |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/25/2008 | CA1341569C Microbial production of human fibroblast interferon |
| 03/20/2008 | WO2008033990A2 Compositions and methods for modulating the notch signal transduction pathway |
| 03/20/2008 | WO2008033555A2 High-pressure refolding of difficult-to-fold proteins |
| 03/20/2008 | WO2008033545A2 Triphenylphosphine oxide derivatives and uses thereof |
| 03/20/2008 | WO2008033451A2 Protein aggregation domains from prions and methods of use thereof |
| 03/20/2008 | WO2008033395A2 Melanocortin and transferrin fusion proteins |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008033333A2 Il-1 family variants |
| 03/20/2008 | WO2008033106A1 Binding domain of plasmodium reticulocyte binding proteins |
| 03/20/2008 | WO2008033044A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 03/20/2008 | WO2008032874A1 Method for screening for agent capable of controlling in vivo hypoxia-responsive system |
| 03/20/2008 | WO2008032783A1 Artificial antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032757A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the alsabc operon |
| 03/20/2008 | WO2008032695A1 A/d converter and a/d converting method |
| 03/20/2008 | WO2008032694A1 A/d converter and a/d converting method |
| 03/20/2008 | WO2008032659A1 Secretion signal peptide having improved efficiency, and method for production of protein by using the same |
| 03/20/2008 | WO2008032607A1 A/d converter, a/d converting method, a/d converting program and control apparatus |
| 03/20/2008 | WO2008032093A1 Cancer treatment |
| 03/20/2008 | WO2008032092A1 Method and kit for detecting if an individual is susceptible to progress to an active mycobacterial disease |
| 03/20/2008 | WO2008032053A1 Fhr-4a splicing variants |
| 03/20/2008 | WO2008032035A1 Expression of tgf-beta in plastids |
| 03/20/2008 | WO2008031878A1 A composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases |
| 03/20/2008 | WO2008031854A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | WO2008031612A1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 03/20/2008 | WO2008031430A2 Doubly transgenic non-human mammal |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2008031164A1 Crystal structures of both isoforms of human glutamic acid decarboxylase |
| 03/20/2008 | WO2008031133A2 Borrelia antigens |
| 03/20/2008 | WO2008018103B1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 03/20/2008 | WO2008016854A3 Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity |
| 03/20/2008 | WO2008015380A3 Integral membrane protein of the pmp-22/emp/mp20/ claudin-like family |
| 03/20/2008 | WO2008010840A3 Fsh mutants |
| 03/20/2008 | WO2008009565A3 Method for screening an enhancer or a masker of salty taste |
| 03/20/2008 | WO2008006103A3 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 03/20/2008 | WO2008003750A3 New protein conjugates and methods for their preparation |
| 03/20/2008 | WO2007137591A3 Hiv vaccine |
| 03/20/2008 | WO2007121895A3 Hpv-16-based papillomavirus vaccine |
| 03/20/2008 | WO2007121894A3 Hpv-18-based papillomavirus vaccine |
| 03/20/2008 | WO2007110079A3 Targeted delivery of fgfr ligands into the brain |
| 03/20/2008 | WO2007100535A3 Oxyntomodulin derivatives |
| 03/20/2008 | WO2007092861A3 Inhibitors specific of presenilin-1 and their uses |
| 03/20/2008 | WO2007092704A3 Genes for enhancing nitrogen utilization efficiency in crop plants |
| 03/20/2008 | WO2007075318A3 Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof |
| 03/20/2008 | WO2007053502A3 Mutations and polymorphisms of hdac5 |
| 03/20/2008 | WO2007047938A3 Influenza viruses able to infect canids, uses thereof |
| 03/20/2008 | WO2006076741A3 Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use |
| 03/20/2008 | WO2005105840A3 Cd40 variants and uses thereof |
| 03/20/2008 | WO2004111075A3 Alternative reading frame polypeptides for treatment |
| 03/20/2008 | US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 03/20/2008 | US20080072347 Transcription factor stress-related proteins and methods of use in plants |
| 03/20/2008 | US20080071312 Ultrasonic treatment of skin conditions or disorders, cancer, as well as muscular/skeletal regeneration |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070865 Inhibiting a taste modulating protein; used in pharmaceutical, food, and other products to inhibit certain taste functions and perceptions; side effects reduction |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080070853 Peptides Selectively Lethal to Malignant and Transformed Mammalian Cells |
| 03/20/2008 | US20080070842 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 03/20/2008 | US20080070840 Polypeptides or peptides modified to include at least one antibody Fc region and, optionally, one or more water soluble polymers; have ability to stimulate in vivo and in vitro production of platelets, and/or megakaryocytopoietic activity, i.e., the ability to stimulate production of platelet precursors |
| 03/20/2008 | US20080070839 Composition and method for treating cancer |
| 03/20/2008 | US20080070837 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| 03/20/2008 | US20080070832 Subjecting a liquid containing FSH to a dye affinity chromatography, a hydrophobic interaction chromatography, and a reverse phase chromatography, which may be performed in any order; avoids the use of cost-intensive immunoaffinity chromatography steps |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |